TRUE AHF

Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decompensated Heart Failure